Dual-energy CT iodine concentration as a biomarker for immunotherapy treatment response in metastatic melanoma and renal cell carcinoma patients.

Saved in:
Bibliographic Details
Title: Dual-energy CT iodine concentration as a biomarker for immunotherapy treatment response in metastatic melanoma and renal cell carcinoma patients.
Authors: Wiley N; Department of Radiology, University of Washington, Seattle, WA, USA., Zecevic M; Department of Radiology, University of Washington, Seattle, WA, USA., Ho V; Department of Radiology, University of Washington, Seattle, WA, USA., Stolzberg MJ; Department of Radiology, University of Washington, Seattle, WA, USA., Cox D; Department of Radiology, University of Washington, Seattle, WA, USA., Soloff EV; Department of Radiology, University of Washington, Seattle, WA, USA., Hall E; Division of Hematology and Oncology, University of Washington, Seattle, WA, USA., Wang CL; Department of Radiology, University of Washington, Seattle, WA, USA. wangcl@uw.edu.
Source: European radiology [Eur Radiol] 2025 Aug; Vol. 35 (8), pp. 4417-4428. Date of Electronic Publication: 2025 Jan 28.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9114774 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1084 (Electronic) Linking ISSN: 09387994 NLM ISO Abbreviation: Eur Radiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-1084
DOI:10.1007/s00330-025-11351-4